Bausch Health (BHC)
(Delayed Data from NYSE)
$8.48 USD
-0.28 (-3.20%)
Updated Nov 15, 2024 04:00 PM ET
After-Market: $8.48 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth F Momentum A VGM
Bausch Health (BHC) Price Targets
| Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
|---|---|---|---|
| $8.57 | $12.00 | $3.00 | -2.17% |
Find the top stocks with the greatest target price potential and Zacks Rank of 1 or 2
Price Target
Based on short-term price targets offered by seven analysts, the average price target for Bausch Health comes to $8.57. The forecasts range from a low of $3.00 to a high of $12.00. The average price target represents a decline of 2.17% from the last closing price of $8.76.
Analyst Price Targets (7 )
Broker Rating
Bausch Health currently has an average brokerage recommendation (ABR) of 3.13 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by eight brokerage firms. The current ABR compares to an ABR of 3.13 a month ago based on eight recommendations.
Of the eight recommendations deriving the current ABR, one is Strong Buy, representing 12.5% of all recommendations. A month ago, Strong Buy represented 12.5%.
Broker Rating Breakdown
Brokerage Recommendations
| Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 5 | 5 | 4 | 4 |
| Sell | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 |
| ABR | 3.13 | 3.13 | 3.13 | 3.14 | 3.14 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
| Date | Brokerage Firm | Analyst | Previous | Current |
|---|---|---|---|---|
| 11/1/2024 | Cowen & Co. | Michael Nedelcovych | Hold | Hold |
| 11/1/2024 | Not Identified | Not Identified | Hold | Hold |
| 10/15/2024 | Evercore Partners | Umer Raffat | Not Available | Hold |
| 8/7/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
| 8/2/2024 | Piper Sandler | David Amsellem | Strong Sell | Strong Sell |
| 7/10/2024 | Raymond James | Gary Nachman | Not Available | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
| Current ABR | 3.13 |
| ABR (Last week) | 3.13 |
| # of Recs in ABR | 8 |
| Average Target Price | $8.57 |
| LT Growth Rate | NA |
| Industry | Medical - Generic Drugs |
| Industry Rank by ABR | 72 of 252 |
| Current Quarter EPS Est: | 1.13 |
BHC FAQs
Bausch Health Cos Inc. (BHC) currently has an average brokerage recommendation (ABR) of 3.13 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 8 brokerage firms.
The average price target for Bausch Health Cos Inc. (BHC) is $8.57. The current on short-term price targets is based on 7 reports.
The forecasts for Bausch Health Cos Inc. (BHC) range from a low of $3 to a high of $12. The average price target represents a decline of $2.17 from the last closing price of $8.76.
The current DOWNSIDE for Bausch Health Cos Inc. (BHC) is 2.17%
Based on short-term price targets offered by seven analysts, the average price target for Bausch Health comes to $8.57. The forecasts range from a low of $3.00 to a high of $12.00. The average price target represents a decline of 2.17% from the last closing price of $8.76.